Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Harrington

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Expert Opinion on Investigational Drugs|January 5, 2002
Liposomal cancer chemotherapy: current clinical applications and future prospectsK J Harrington
Gene Therapy|July 30, 2010
Winners and losers and oncolytic adenoviruses: who should be down in the mouth?K J Harrington
Lancet (London, England)|October 31, 1997
Radical surgery versus radiotherapy for stage Ib-IIa cervical cancerK J Harrington, H Thomas
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
The search for optimal chemotherapy for advanced epithelial ovarian cancerK J Harrington, H E Lambert
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Recent developments in radioimmunotherapyK J Harrington, A A Epenetos
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 16, 2013
The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiologyJ S Good, K J Harrington
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Current issues in the non-surgical management of primary vulvar squamous cell carcinomaK J Harrington, H E Lambert
Current Pharmaceutical Design|March 9, 2012
Radiovirotherapy: principles and prospects in oncologyY Touchefeu, P Franken, K J Harrington
Advanced Drug Delivery Reviews|November 10, 2000
Transcriptional control: an essential component of cancer gene therapy strategies?K J Harrington, E Linardakis, R G Vile
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 23, 2002
Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules -- lessons from liposomes and monoclonal antibodiesK J Harrington, M Mubashar, A M Peters
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Expert Opinion on Investigational Drugs|January 5, 2002
Liposomal cancer chemotherapy: current clinical applications and future prospectsK J Harrington
Gene Therapy|July 30, 2010
Winners and losers and oncolytic adenoviruses: who should be down in the mouth?K J Harrington
Lancet (London, England)|October 31, 1997
Radical surgery versus radiotherapy for stage Ib-IIa cervical cancerK J Harrington, H Thomas
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
The search for optimal chemotherapy for advanced epithelial ovarian cancerK J Harrington, H E Lambert
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Recent developments in radioimmunotherapyK J Harrington, A A Epenetos
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 16, 2013
The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiologyJ S Good, K J Harrington
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Current issues in the non-surgical management of primary vulvar squamous cell carcinomaK J Harrington, H E Lambert
Current Pharmaceutical Design|March 9, 2012
Radiovirotherapy: principles and prospects in oncologyY Touchefeu, P Franken, K J Harrington
Advanced Drug Delivery Reviews|November 10, 2000
Transcriptional control: an essential component of cancer gene therapy strategies?K J Harrington, E Linardakis, R G Vile
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 23, 2002
Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules -- lessons from liposomes and monoclonal antibodiesK J Harrington, M Mubashar, A M Peters
Pageof 13